ALDOA and familial pancreatic carcinoma: ALDOA, the gene encoding the glycolysis enzyme that converts fructose-1,6-bisphosphate to glyceraldehyde-3-phosphate, has been shown to correlate with poor prognosis in pancreatic cancer patients [38].